- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular Imaging and Therapy for Neuroendocrine Tumors
Authors
Keywords
Somatostatin receptor, PET/CT, Peptide receptor radionuclide therapy (PRRT), DOTATATE, MIBG, Theranostic
Journal
CURRENT TREATMENT OPTIONS IN ONCOLOGY
Volume 20, Issue 10, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-29
DOI
10.1007/s11864-019-0678-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Current management of neuroblastoma and future direction
- (2019) Elizabeth R. Pastor et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Predictors of survival in 211 patients with stage IV pulmonary and gastroenteropancreatic mIBG positive neuroendocrine tumors treated with I-131 mIBG
- (2018) Ari Kane et al. JOURNAL OF NUCLEAR MEDICINE
- Peptide Receptor Radionuclide Therapy in Grade 3 Neuroendocrine Neoplasms: Safety and Survival Analysis in 69 Patients
- (2018) Jingjing Zhang et al. JOURNAL OF NUCLEAR MEDICINE
- Efficacy and Safety of High-Specific-Activity I-131 MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma
- (2018) Daniel A. Pryma et al. JOURNAL OF NUCLEAR MEDICINE
- Phase 1 Study of High-Specific-Activity I-131 MIBG for Metastatic and/or Recurrent Pheochromocytoma or Paraganglioma
- (2017) Richard B Noto et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Norepinephrine Transporter as a Target for Imaging and Therapy
- (2017) Neeta Pandit-Taskar et al. JOURNAL OF NUCLEAR MEDICINE
- Persistent Hematologic Dysfunction after Peptide Receptor Radionuclide Therapy with177Lu-DOTATATE: Incidence, Course, and Predicting Factors in Patients with Gastroenteropancreatic Neuroendocrine Tumors
- (2017) Hendrik Bergsma et al. JOURNAL OF NUCLEAR MEDICINE
- Peptide Receptor Radionuclide Treatment and (131)I-MIBG in the management of patients with metastatic/progressive phaeochromocytomas and paragangliomas
- (2017) Konstantinos Nastos et al. JOURNAL OF SURGICAL ONCOLOGY
- Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
- (2017) Jonathan Strosberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
- (2017) Arvind Dasari et al. JAMA Oncology
- Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging, and Treatment Management of Neuroendocrine Tumors
- (2016) S. A. Deppen et al. JOURNAL OF NUCLEAR MEDICINE
- Peptide receptor radionuclide therapy for metastatic paragangliomas
- (2016) David J. Pinato et al. MEDICAL ONCOLOGY
- Erratum to: The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours
- (2013) L. Bodei et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- One-Year Progression-Free Survival of Therapy-Naive Patients With Malignant Pheochromocytoma and Paraganglioma
- (2013) Ségolène Hescot et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Long-Term Outcome and Toxicity After Dose-Intensified Treatment with 131I-MIBG for Advanced Metastatic Carcinoid Tumors
- (2013) S. Ezziddin et al. JOURNAL OF NUCLEAR MEDICINE
- Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT Within Patients with Gastroenteropancreatic Neuroendocrine Tumors
- (2013) D. Wild et al. JOURNAL OF NUCLEAR MEDICINE
- Promising Therapeutic Targets in Neuroblastoma
- (2012) K. K. Matthay et al. CLINICAL CANCER RESEARCH
- EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma
- (2012) David Taïeb et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- High management impact of Ga-68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours
- (2012) Michael S Hofman et al. Journal of Medical Imaging and Radiation Oncology
- I-131-MIBG therapies
- (2011) Stefan Vöö et al. METHODS
- Safety and efficacy of tandem 131I-metaiodobenzylguanidine infusions in relapsed/refractory neuroblastoma
- (2011) Kelsey Johnson et al. PEDIATRIC BLOOD & CANCER
- 131I-Metaiodobenzylguanidine Therapy of Neuroblastoma and Other Neuroendocrine Tumors
- (2010) Frank Grünwald et al. SEMINARS IN NUCLEAR MEDICINE
- Efficacy of using a standard activity of 131I-MIBG therapy in patients with disseminated neuroendocrine tumours
- (2009) Shaunak Navalkissoor et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Phase II Study of High-Dose [131I]Metaiodobenzylguanidine Therapy for Patients With Metastatic Pheochromocytoma and Paraganglioma
- (2009) Sara Gonias et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival
- (2008) Dik J. Kwekkeboom et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started